Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Understanding The Prospects Of Endocyte
Seeking Alpha
Tuesday, May 1, 2012 - 7:14am
tags:
Endocyte, Merck
Amarin up on Citi projections for cholesterol drug
Yahoo/AP
Tuesday, May 1, 2012 - 7:04am
tags:
Amarin, AMR101
Whisper Number Impact: Earnings Preview For Pfizer And Biogen Idec
Seekin Alpha
Tuesday, May 1, 2012 - 7:03am
tags:
earnings, Biogen Idec, Pfizer
Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville
Monday, April 30, 2012 - 10:12pm
tags:
Pfizer, Arena Pharmaceuticals, Gilead Sciences, Vyndaqel, JNJ, Xarelto, ASCO, Talon Therapeutics, Marqibo, Quad, Truvada, lorcaserin, Protalix BioTherapeutics, Alexza, Adasuve, Arcalyst, Regeneron, Abbott Laboratories, Remicade
Is This Biotech Trying to Distract Investors?
Motley Fool
Monday, April 30, 2012 - 10:08pm
tags:
Cell Therapeutics
Double-Digit Upside For Merck, Mylan Tops BioPharma
Seeking Alpha
Monday, April 30, 2012 - 10:00pm
tags:
Mylan, Merck, Bristol-Myers Squibb
Watson Q1 Beats Expectations; Eyes Actavis Closing
Investors.com
Monday, April 30, 2012 - 1:07pm
tags:
earnings, Watson Pharmaceuticals, Actavis
Vivus: Who Leaked Word Of Stendra Approval?
Seeking Alpha
Monday, April 30, 2012 - 1:06pm
tags:
Stendra, Vivus, Avanafil, erectile dysfunction
Dynavax: Let The Show Begin!
Seeking Alpha
Monday, April 30, 2012 - 1:04pm
tags:
Dynavax, Heplisav, GSK, hepatitis B, AstraZeneca
MannKind says it could get $130M and royalties after licensing drug candidates to Tolero
Yahoo/AP
Monday, April 30, 2012 - 11:20am
tags:
MannKind, Tolero
Teva settles Nuvigil litigation with Mylan
Yahoo/Businesswire
Monday, April 30, 2012 - 10:59am
tags:
Teva Pharmaceuticals, NUVIGIL, Mylan, generics
Warner Chilcott says it's in early talks that could lead to sale of company, shares soar
Yahoo/AP
Monday, April 30, 2012 - 10:58am
tags:
M&A, Warner Chilcott
Biotech venture rounds dwindle in Europe, tracking U.S. trend
Fierce Biotech
Monday, April 30, 2012 - 10:27am
tags:
biotech, Europe, venture capital
Actelion Lung Drug Meets Main Goal in Pivotal Study
Bloomberg
Monday, April 30, 2012 - 10:21am
tags:
Actelion, macitentan, pulmonary arterial hypertension, PAH
Don't Get Suckered In By Friday's Strong Rally In Arena Pharmaceuticals
Seeking Alpha
Monday, April 30, 2012 - 10:18am
tags:
Arena Pharmaceuticals, lorcaserin, Orexigen, Vivus
Spectrum: Increased Fusilev Production May Boost Stock
Seeking Alpha
Monday, April 30, 2012 - 10:17am
tags:
Spectrum, Fusilev, Abbott Laboratories, AstraZeneca, colorectal cancer, GSK, Biogen Idec, Eli Lilly
Ampio announecs extended analysis of Ampion in knee shows pain relief
The Fly on the Wall
Monday, April 30, 2012 - 10:16am
tags:
Ampio, Ampion Pharmaceuticals, knee pain
Aegerion Pharma announces FDA acceptance of NDA for review of lomitapide
The Fly on the Wall
Monday, April 30, 2012 - 10:14am
tags:
FDA, lomitapide, Aegerion, Homozygous Familial Hypercholesterolemia
On The Heels Of Chemo-Approved Cancer Drugs
Seeking Alpha
Monday, April 30, 2012 - 10:13am
tags:
Eli Lilly, Merck, Northwest Biotherapeutics, Roche, brain cancer, Temodar, Erbitux, DCVax, Avastin
Investor Demands On Astra's Cash Shows Industry Must Improve R&D Prowess
Seeking Alpha
Monday, April 30, 2012 - 10:10am
tags:
investors, R&D, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.